Anavex Announces Fiscal 2014 Fourth Quarter and Year-End Financial Results

New York, NY – December 30, 2014 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (OTCQX: AVXL), a clinical-stage biopharmaceutical company developing novel drug candidates to treat Alzheimer’s disease, other diseases of the central nervous system (CNS) and various types of cancer, today reported fourth quarter and year-end results for fiscal year 2014. Upcoming…